RY

164.93

+0.18%↑

TD

96.61

+0.9%↑

BMO

137.29

-0.18%↓

CM

97.91

+0.95%↑

BNS

69.74

-0.87%↓

RY

164.93

+0.18%↑

TD

96.61

+0.9%↑

BMO

137.29

-0.18%↓

CM

97.91

+0.95%↑

BNS

69.74

-0.87%↓

RY

164.93

+0.18%↑

TD

96.61

+0.9%↑

BMO

137.29

-0.18%↓

CM

97.91

+0.95%↑

BNS

69.74

-0.87%↓

RY

164.93

+0.18%↑

TD

96.61

+0.9%↑

BMO

137.29

-0.18%↓

CM

97.91

+0.95%↑

BNS

69.74

-0.87%↓

RY

164.93

+0.18%↑

TD

96.61

+0.9%↑

BMO

137.29

-0.18%↓

CM

97.91

+0.95%↑

BNS

69.74

-0.87%↓

Search

Hercules Capital Inc

Ouvert

SecteurFinance

15.08

Résumé

Variation du prix de l'action

24h

Actuel

Min

15.01

Max

15.19

Chiffres clés

By Trading Economics

Revenu

-28M

91M

Ventes

-12M

158M

P/E

Moyenne du Secteur

7.676

55.155

BPA

0.48

Rendement du dividende

11.52

Marge bénéficiaire

57.578

Employés

100

EBITDA

-3.5M

116M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+29.19% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

11.52%

4.95%

Prochains Résultats

30 avr. 2026

Date du Prochain Dividende

19 mai 2026

Date du Prochain Détachement de Dividende

12 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-444M

2.6B

Ouverture précédente

15.08

Clôture précédente

15.08

Sentiment de l'Actualité

By Acuity

50%

50%

160 / 440 Classement par Finance

Score Technique

By Trading Central

Confiance

Neutral Evidence

Hercules Capital Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

6 avr. 2026, 23:17 UTC

Résultats

Samsung Forecasts Record First-Quarter Operating Profit

6 avr. 2026, 23:00 UTC

Actions en Tendance

Stocks to Watch: Health Insurers, Mawson, Owlet

6 avr. 2026, 22:13 UTC

Principaux Mouvements du Marché

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6 avr. 2026, 21:46 UTC

Acquisitions, Fusions, Rachats

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6 avr. 2026, 17:09 UTC

Principaux Mouvements du Marché

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6 avr. 2026, 16:56 UTC

Principaux Événements d'Actualité

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6 avr. 2026, 14:47 UTC

Principaux Mouvements du Marché

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7 avr. 2026, 00:00 UTC

Principaux Événements d'Actualité

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6 avr. 2026, 23:58 UTC

Market Talk
Principaux Événements d'Actualité

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6 avr. 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6 avr. 2026, 23:36 UTC

Market Talk

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6 avr. 2026, 23:15 UTC

Market Talk

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6 avr. 2026, 22:52 UTC

Market Talk

Global Equities Roundup: Market Talk

6 avr. 2026, 22:52 UTC

Market Talk

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6 avr. 2026, 22:14 UTC

Market Talk

Correction to Live Cattle Futures Article

6 avr. 2026, 20:56 UTC

Market Talk

Mexican Private Consumption Fell in January -- Market Talk

6 avr. 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

6 avr. 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6 avr. 2026, 19:58 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6 avr. 2026, 19:58 UTC

Market Talk

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6 avr. 2026, 19:11 UTC

Market Talk

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6 avr. 2026, 19:06 UTC

Market Talk

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6 avr. 2026, 19:03 UTC

Market Talk

Global Energy Roundup: Market Talk

6 avr. 2026, 19:03 UTC

Market Talk

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6 avr. 2026, 18:36 UTC

Acquisitions, Fusions, Rachats

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 avr. 2026, 17:59 UTC

Market Talk
Principaux Événements d'Actualité

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6 avr. 2026, 17:13 UTC

Acquisitions, Fusions, Rachats

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 avr. 2026, 16:33 UTC

Market Talk

Oil Futures Steady as Market Awaits Trump -- Market Talk

6 avr. 2026, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

6 avr. 2026, 14:59 UTC

Résultats

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Comparaison

Variation de prix

Hercules Capital Inc prévision

Objectif de Prix

By TipRanks

29.19% hausse

Prévisions sur 12 Mois

Moyen 19.25 USD  29.19%

Haut 25 USD

Bas 15 USD

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

6 ratings

4

Achat

2

Maintien

0

Vente

Score Technique

By Trading Central

17.41 / 17.93Support & Résistance

Court Terme

Neutral Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

160 / 440Classement par Finance

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Moyen

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Hercules Capital Inc

Hercules Capital, Inc. is a business development company. The firm specializing in providing private equity, venture debt, and growth capital to privately held venture capital-backed companies at all stages of development from mid venture to expansion stage including select publicly listed companies and select special opportunity companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, SaaS Finance, energy technology, sustainable
help-icon Live chat